Genome instability is the fundamental hallmark of malignant
tumors.
Tumor suppressors often play a role in maintaining
genome stability. Our previous genetic screen identified
inositol polyphosphate 4-phosphatase type B (INPP4B), primarily hydrolyzing
phosphatidylinositol 3, 4-disphosphate, is a potential
tumor suppressor in
lung cancer cells. How INPP4B regulates the
genome stability of
lung cancer cells is unclear. Here we report knockout of INPP4B in
lung adenocarcinoma A549 cells by Crispr-Cas9 gene editing leads to sensitization to ionizing radiation (IR),
PARP inhibitor olaparib and impaired
DNA homologous recombination repair. Re-introduction of a Crispr-Cas9 resistant INPP4B gene in the INPP4B knockout cells partially restored their resistance to IR, indicating loss of INPP4B
protein is relevant to the increased IR sensitivity. Furthermore, we showed ectopic expressed INPP4B in A549 cells responds to IR irradiation by redistribution from cytoplasm to nucleus and endogenous INPP4B
protein interacts with Rad50, a crucial MRN complex component for tethering
DNA double-strand breaks. Loss of INPP4B
protein results in decreased stability of Rad50 in vivo, suggesting an unanticipated role of
tumor suppressor INPP4B in maintaining genome integrity via facilitating Rad50 mediated
DNA double-strand break repair. Taken together, our findings support a dual role of INPP4B in suppression of
tumorigenesis by safeguarding
genome stability, as well as inhibiting of PI3K-Akt-mTOR signaling, and offer a new therapeutic strategy for personalized
cancer treatment to patients with INPP4B defects or deficiency in the clinic.